Takeda is committed towards accelerating access to innovative medicines? Can you provide more insight on this?
Our Access to Medicines (AtM) initiative is about radically increasing access to innovative medicines for complex and rare diseases by mobilizing collective action to drive impact to patients. This is done through targeted partnerships that strengthen healthcare systems in a sustainable way, at every stage of the patient journey.
Through our AtM programme, we have equipped healthcare providers with diagnostic and treatment training across our therapeutic areas, and also developed collaborative financing models to ensure patients can complete their course of treatment, even when they cannot afford to pay in full. Since Takeda established these Patient Assistance Programmes in 2016, we have impacted the lives of close to 700 patients across APAC.
We are focused on long-term commitments and seek to shape the environment in these countries so that in the long-term, a sustainable reimbursement landscape that also covers complex and rare medical conditions may be possible.
Continue reading your story on the app
Continue reading your story in the magazine
“We plan to launch our prevention and early detection service in India”
London headquartered Medix Global, a provider of innovative, high quality, medical management solutions, is gradually expanding its business in Asia. With its recent entry into India, the company is geared to provide access of its global healthcare services to Indian customers. It has strong credentials for providing customers with fast-tracked and personalized medical solutions, from the right diagnosis to optimized treatment pathways. BioSpectrum Asia spoke to Sigal Atzmon, Founder and CEO, Medix Global, London, UK to find out more about the company’s growth plans in Asia.
“We are planning to launch a new bioprocess controller in Q1 2021”
Bioprocess engineers develop and produce a multitude of products and ingredients available today. Their applications are diverse, and the products can be found in pharmaceutical, chemical, and nutrition industries. With an integrated portfolio comprising software, instruments, consumables, and services, Eppendorf can satisfy the demands of bioprocess development through production. To find out about what major is in store at Eppendorf Bioprocess, BioSpectrum spoke to Richard Mirro, Business Manager, Bioprocess at Eppendorf, Inc., US.
“We are confident that Sputnik V will be providing long-term immunization defence against potential new coronavirus infections”
On December 14, 2020, Moscow’s National Research Center for Epidemiology and Microbiology named ‘Gamaleya Center’ and the Russian Direct Investment Fund (RDIF) announced the efficacy of over 90 per cent of the Russian Sputnik V vaccine in Phase III post-registration clinical trials. RDIF joins partners and manufacturers in ramping up the production of Sputnik V. First batch of 300,000 doses of Sputnik V vaccine has already been delivered to Argentina by RDIF on December 24, 2020. In an interview with BioSpectrum Asia Kirill Dmitriev, CEO, Russian Direct Investment Fund (RDIF), Russia shared more insight on the encouraging efficacy data of the Sputnik V with Biospectrum Asia.
“Australia has reinforced its standing as a world-class destination for early phase clinical development”
Avance Clinical, a leading Australian Contract Research Organization (CRO) for biotech firms, and winner of the prestigious Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award, has recently partnered with Europe’s leading CRO, Cromos Pharma. The collaboration will allow biotech firms to quickly start their pre-IND early phase studies in Australia, thereafter, expanding to Central/Eastern Europe to access the large patient populations for their Phase II and III studies. In an email interaction with BioSpectrum, Yvonne Lungershausen, CEO, Avance Clinical, Australia spoke about the Australian CRO market, and the impact of COVID-19 crisis.
Evaluating COVID-19 vaccines on mutant viral strains
While the viral variants and vaccine trials are contesting with each other, Norway based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a first-of-its-kind collaboration to tackle emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in development. Tracking viral mutations and diversity is essential to ensure efficacy of COVID-19 vaccine candidates on mutant virulent strains.
Taiwan initiates new measures for management of medical masks
Taiwan has initiated two new measures to reinforce the management of medical masks.
Singapore gives nod to Pfizer-BioNTech COVID-19 vaccine
The Health Sciences Authority (HSA) has granted an authorization under the Pandemic Special Access Route (PSAR) for the Pfizer-BioNTech COVID-19 vaccine to be used in Singapore for the prevention of COVID-19.
HiMedia gets multiple nods for COVID-19 products
HiGenoMB, the molecular biology division of Indian firm HiMedia Laboratories has received the CE/IVD approval and a nod from the Indian Council of Medical Research (ICMR) for its COVID-19 range of products.
EuBiologics partners with IVI for COVID-19 vaccine development
The International Vaccine Institute (IVI) and South Korean company EuBiologics have exchanged a Memorandum of Understanding (MoU) to cooperate in the clinical development of the COVID-19 vaccine the company is currently developing.
2021 beckons MAJOR investments IN R&D
The life sciences industry in Asia Pacific (APAC) region entered the year 2020 with companies entering into new agreements for expansion and focusing on applied research to develop new drugs that are affordable. During 2020, the industry, which acted timely, as covered in the January 2020 issue of BioSpectrum Asia, witnessed unprecedented collaborations with the governments due to the unexpected spread of coronavirus since December 2019. COVID-19 is expected to remain a defining issue for the life sciences industry across the globe in 2021, compelling companies to invest heavily in research and development.
Zika Is the Next Front in the Mosquito Wars
Based on damage from malaria and dengue, the spread of Zika will prove costly.
Trust is the cornerstone of secure access leader Dormakaba. For senior Vice President operations APAC oliver riess, this extends beyond solutions to the culture of the company itself.
MANAGEMENT OF CO-INFECTION OF COVID-19 WITH OTHER SEASONAL EPIDEMIC PRONE DISEASES
Almost all States/UTs of the country are affected by COVID-19. Given the seasonal pattern of epidemic-prone diseases observed every year in our country, it diseases like Dengue, Malaria, Seasonal Influenza, Leptospirosis, Chikungunya, Enteric fever, etc. can not only present as a diagnostic dilemma but may co-exist in COVID cases.
Korn Ferry's Gareth McIlroy on jobs, skills, and changing workplace dynamics
For years organizations have been talking about digital transformation, but the pandemic has grabbed the concept and made it an absolute imperative for survival, says Gareth Mcilroy, Managing Director, Korn Ferry, Singapore, in an interaction with People Matters
Dairy: A New Era of Innovation
Although most countries produce milk products, the structure of the dairy industry differs across the globe. Many major dairy-producing countries consume most of their output internally, while others (for example New Zealand) export a large percentage of their production. Local consumption is often in the form of liquid milk, while the bulk of international trade is in processed dairy products such as milk powder.
Stop the Fall
Worried about your falling hair? Dr. Shefali Trasi Nerurkar - MD Skin, Consultant Dermatologist at Dr. Trasi’s Clinic & La Piel details the underlying causes of hairfall and hairloss to help you tackle this common haircare problem.
डेंगू विरोधी अभियान के कारण इस साल भी नहीं हुई डेंगू से कोई मौत : केजरीवाल
दिल्ली के लोगों से अभियान में शामिल होने की अपील
Regina Lim Makes A Case For The Physical
In a time where everyone is going virtual, Regina Lim, head of capital markets research, APAC at JLL, makes a case for the physical.
डेंगू अभियान में जुटे बच्चे, सीएम ने सराहा
केजरीवाल ने अपने घर में रुके हुए साफ पानी को बदला
कोरोना व डेंगू से पीड़ित डिप्टी सीएम सिसोदिया को दी गई प्लाज्मा थेरेपी
कोविड-19 : एलएनजेपी अस्पताल से मैक्स अस्पताल में किया शिफ्ट